SCHEMBL2635489

SCHEMBL2635489

CC(C)c1cc(Br)c[nH]c1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC1 P07992 1/20 0.50
ERCC4 Q92889 1/20 0.50
GABRA1 P14867 1/20 0.43
GABRB1 P18505 1/20 0.43
ALDH1A1 P00352 4/20 0.40
CHEK1 O14757 1/20 0.38
AURKA O14965 1/20 0.38
MAP4K4 O95819 1/20 0.38
ABL1 P00519 1/20 0.38
CSF1R P07333 1/20 0.38
RET P07949 1/20 0.38
MET P08581 1/20 0.38
FGFR1 P11362 1/20 0.38
PDGFRA P16234 1/20 0.38
FLT1 P17948 1/20 0.38
LTK P29376 1/20 0.38
GRK5 P34947 1/20 0.38
CSNK1A1 P48729 1/20 0.38
CDK8 P49336 1/20 0.38
CLK2 P49760 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2635796 0.80 ERCC1 (0.47) ERCC1ERCC4GABRA1GABRB1ALDH1A1
SCHEMBL2635354 0.80 ERCC1 (0.43) ERCC1ERCC4ALDH1A1CREBBPBACE1
SCHEMBL9949061 0.79 ERCC1 (0.50) ERCC1ERCC4ALDH1A1CREBBPBACE1
SCHEMBL23488021 0.77 DAO (0.52) CHEK1AURKAMAP4K4ABL1CSF1R
SCHEMBL22185347 0.77 FABP4 (0.41) GABRA1GABRB1ALDH1A1CHEK1AURKA
SCHEMBL20028266 0.75 DAO (0.50) GABRA1GABRB1CHEK1AURKAMAP4K4
SCHEMBL15468987 0.75 CHEK1 (0.38) ERCC1ERCC4ALDH1A1CHEK1AURKA
SCHEMBL28669845 0.75 DAO (0.41) ERCC1ERCC4GABRA1GABRB1CHEK1
SCHEMBL2635821 0.73 ERCC1 (0.41) ERCC1ERCC4GABRA1GABRB1ALDH1A1
SCHEMBL13843689 0.72 CHEK1 (0.36) ALDH1A1CHEK1AURKAMAP4K4ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146512-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 WO disclosed
EP-2569313-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Vertex Pharmaceuticals Incorporated (US) 2013-03-20 EP disclosed
WO-2011143426-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-11-17 WO disclosed